MTP 059xTB in the Third MillenniumClinical questions to be addressed:Who should be screened today for latent tuberculosis infection?What is the utility of rapid PCR tests?Should the new QUANTiferon assay replace the traditional Mantoux tuberculin test?What alternatives are there to INH for chemoprophylaxis? What is recommended for probable MDR or especially XDR latent infection?When should MDR or especially XDR tuberculosis be suspected?Is there becoming a role for BCG in North America? Where do we stand on a better TB vaccine?How does global and local epidemiology help the clinician decide how to manage a particular patient?